Interactions between endothelial selectins and cancer cells regulate metastasis

Frontiers in Bioscience

Volumn 16, Issue 8, 2011, Pages 3233-3251

  St Hill, Catherine A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cytokines; Inflammation; Leukocytes; Metastasis; Neoplasms; Neutrophils; Oligosaccharides; Review; Selectins; Signal transduction

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LIGAND; PADGEM PROTEIN; SELECTIN;

ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; ENDOTHELIUM CELL; GENETICS; HUMAN; INFLAMMATION; METASTASIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ANIMALS; E-SELECTIN; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; LIGANDS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; P-SELECTIN; SELECTINS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 79959609564     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3909     Document Type: Review

References (198)

1. R. M. Lafrenie, M. R. Buchanan and F. W. Orr: Adhesion molecules and their role in cancer metastasis. Cell Biophys, 23, 3-89 (1993)
2. G. Mannori, P. Crottet, O. Cecconi, K. Hanasaki, A. Aruffo, R. M. Nelson, A. Varki and M. P. Bevilacqua: Differential colon cancer cell adhesion to E-, P-, and Lselectin: role of mucin-type glycoproteins. Cancer Res, 55, 4425-4431 (1995)
3. E. C. Butcher: Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell, 67, 1033-6 (1991) (Pubitemid 121001517)
4. I. J. Fidler: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer, 3, 453-8 (2003) (Pubitemid 37328849)
5. F. G. Hanisch, C. Hanski and A. Hasegawa: Sialyl Lewis(x) antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence. Cancer Res 52, 3138-44 (1992)
6. P. Brodt, L. Fallavollita, R. S. Bresalier, S. Meterissian, C. R. Norton and B. A. Wolitzky: Liver endothelial Eselectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer, 71, 612-619 (1997) (Pubitemid 27239372)
7. L. Borsig, R. Wong, R. O. Hynes, N. M. Varki and A. Varki: Synergistic effects of L-and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci USA, 99, 2193-2198 (2002) (Pubitemid 34169037)
8. Y. J. Kim, L. Borsig, H.-L. Han, N. M. Varki and A. Varki: Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol, 155, 461-472 (1999) (Pubitemid 29370396)
9. T. A. Springer: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76, 301-14 (1994) (Pubitemid 24046692)
10. K. Ley and G. S. Kansas: Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation. Nat Rev Immunol, 4, 325-35 (2004) (Pubitemid 38649275)
11. G. S. Kansas: Selectins and their ligands: current concepts and controversies. Blood, 88, 3259-3287 (1996) (Pubitemid 26365560)
12. M. Morigi, C. Zoja, M. Figliuzzi, M. Foppolo, G. Micheletti, M. Bontempelli, M. Saronni, G. Remuzzi and A. Remuzzi: Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells. Blood, 85, 1696-703 (1995)
13. M. Subramaniam, J. A. Koedam and D. D. Wagner: Divergent fates of P- and E-selectins after their expression on the plasma membrane. Mol Biol Cell, 4, 791-801 (1993) (Pubitemid 23274240)
14. D. B. Cines, E. S. Pollak, C. A. Buck, J. Loscalzo, G. A. Zimmerman, R. P. McEver, J. S. Pober, T. M. Wick, B. A. Konkle, B. S. Schwartz, E. S. Barnathan, K. R. McCrae, B. A. Hug, A. M. Schmidt and D. M. Stern: Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood, 91, 3527-61 (1998) (Pubitemid 28225719)
15. P. von Hundelshausen and C. Weber: Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res, 100, 27-40 (2007) (Pubitemid 46066771)
16. R. Hattori, K. K. Hamilton, R. D. Fugate, R. P. McEver and P. J. Sims: Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem, 264, 7768-71 (1989) (Pubitemid 19137247)
17. D. Vestweber and J. E. Blanks: Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev, 79, 181-213 (1999) (Pubitemid 29056952)
18. J. F. Leeuwenberg, E. F. Smeets, J. J. Neefjes, M. A. Shaffer, T. Cinek, T. M. Jeunhomme, T. J. Ahern and W. A. Buurman: E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology, 77, 543-9 (1992) (Pubitemid 23000475)
19. R. Pigott, L. P. Dillon, I. H. Hemingway and A. J. Gearing: Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun, 187, 584-9 (1992)
20. G. Davi, M. Romano, A. Mezzetti, A. Procopio, S. Iacobelli, T. Antidormi, T. Bucciarelli, P. Alessandrini, F. Cuccurullo and G. Bittolo Bon: Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation, 97, 953-957 (1998) (Pubitemid 28125466)
21. P. André, D. Hartwell, I. Hrachovinová, S. Saffaripour and D. D. Wagner: Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A, 97, 13835-40 (2000)
22. K. M. Schweitzer, A. M. Drager, P. van der Valk, T. SF, A. Zevenbergen, A. P. Theijsmeijer, C. E. van der Schoot and M. M. Langenhuijsen: Constitutive expression of E-selectin and vascular cell adhesion molecule-1 on endothelial cells of hematopoietic tissues. Am J Pathol, 148, 165-175 (1996)
23. D. Nolte, P. Schmid, U. Jäger, A. Botzlar, F. Roesken, R. Hecht, E. Uhl, K. Messmer and D. Vestweber: Leukocyte rolling in venules of striated muscle and skin is mediated by P-selectin, not by L-selectin. Am J Physiol, 267, H1637-42 (1994)
24. K. Ley: The role of selectins in inflammation and disease. Trends Mol Med, 9, 263-8 (2003) (Pubitemid 36841686)
25. B. Schleiffenbaum, O. Spertini and T. F. Tedder: Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol, 119, 229-38 (1992)
26. J. W. Homeister, A. D. Thall, B. Petryniak, P. Malý, C. E. Rogers, P. L. Smith, R. J. Kelly, K. M. Gersten, S. W. Askari, G. Cheng, G. Smithson, R. M. Marks, A. K. Misra, O. Hindsgaul, U. H. von Andrian and J. B. Lowe: The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity, 15, 115-26 (2001) (Pubitemid 32728325)
27. P. L. Smith, J. T. Myers, C. E. Rogers, L. Zhou, B. Petryniak, D. J. Becker, J. W. Homeister and J. B. Lowe: Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus. J Cell Biol, 158, 801-15 (2002) (Pubitemid 34920117)
28. A. Etzioni, M. Frydman, S. Pollack, I. Avidor, M. L. Phillips, J. C. Paulson and R. Gershoni-Baruch: Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med, 327, 1789-92 (1992)
29. A. Takada, K. Ohmori, T. Yoneda, K. Tsuyuoka, A. Hasegawa, M. Kiso and R. Kannagi: Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res, 53, 354-361 (1993) (Pubitemid 23031849)
30. R. P. McEver and C. Zhu: Rolling cell adhesion. Annu Rev Cell Dev Biol, 26, 363-96 (2010)
31. P. S. Frenette, C. Moyna, D. W. Hartwell, J. B. Lowe, R. O. Hynes and D. D. Wagner: Platelet-endothelial interactions in inflamed mesenteric venules. Blood, 91, 1318-24 (1998) (Pubitemid 28086885)
32. X. Yin, K. Rana, V. Ponmudi and M. R. King: Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion. Carbohydr Res, 345, 2334-42 (2010)
33. M. Trinchera, N. Malagolini, M. Chiricolo, D. Santini, F. Minni, A. Caretti and F. Dall'olio: The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach. Int J Biochem Cell Biol, 43, 130-9 (2011)
34. R. P. McEver and R. D. Cummings: Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest, 100, 485-491 (1997)
35. A. Leppänen, S. P. White, J. Helin, R. P. McEver and R. D. Cummings: Binding of glycosulfopeptides to Pselectin requires stereospecific contributions of individual tyrosine sulfate and sugar residues. J Biol Chem, 275, 39569-39578 (2000) (Pubitemid 32058983)
36. K. R. Snapp, H. Ding, K. Atkins, R. Warnke, F. W. Luscinskas and G. S. Kansas: A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin. Blood 91, 154-64 (1998) (Pubitemid 28018740)
37. S. Aigner, C. L. Ramos, A. Hafezi-Moghadam, M. B. Lawrence, J. Friederichs, P. Altevogt and K. Ley: CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J, 12, 1241-51 (1998) (Pubitemid 28418954)
38. P. Kotovuori, E. Tontti, R. Pigott, M. Shepherd, M. Kiso, A. Hasegawa, R. Renkonen, P. Nortamo, D. C. Altieri and C. G. Gahmberg: The vascular E-selectin binds to the leukocyte integrins CD11/CD18. Glycobiology, 3, 131-6 (1993) (Pubitemid 23132603)
39. C. J. Dimitroff, J. Y. Lee, S. Rafii, R. C. Fuhlbrigge and R. Sackstein: CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. J Cell Biol, 153, 1277-86 (2001) (Pubitemid 34289265)
40. L. J. Picker, R. A. Warnock, A. R. Burns, C. M. Doerschuk, E. L. Berg and E. C. Butcher: The neutrophil selectin LECAM-1 presents carbohydrate ligands to the vascular selectins ELAM-1 and GMP-140. Cell, 66, 921-33. Erratum in: Cell 1991 Dec 20;67(6):1267. (1991) (Pubitemid 121001726)
41. H. Läubli and L. Borsig: Selectins promote tumor metastasis. Semin Cancer Biol, 20, 169-77 (2010)
42. R. C. Fuhlbrigge, S. L. King, R. Sackstein and T. S. Kupper: CD43 is a ligand for E-selectin on CLA+ human T cells. Blood, 107, 1421-6 (2006) (Pubitemid 43242377)
43. M. Steegmaier, A. Levinovitz, S. Isenmann, E. Borges, M. Lenter, H. P. Kocher, B. Kleuser and D. Vestweber: The E-selectin-ligand ESL-1 is a variant of a receptor for fibroblast growth factor. Nature, 373, 615-20 (1995)
44. S. D. Rosen, D. Tsay, M. S. Singer, S. Hemmerich and W. M. Abraham: Therapeutic targeting of endothelial ligands for L-selectin (PNAd) in a sheep model of asthma. Am J Pathol, 166, 935-44 (2005) (Pubitemid 40315649)
45. C. Kneuer, C. Ehrhardt, M. W. Radomski and U. Bakowsky: Selectins-potential pharmacological targets? Drug Discov Today, 11, 1034-40 (2006)
46. L. Deban, R. C. Russo, M. Sironi, F. Moalli, M. Scanziani, V. Zambelli, I. Cuccovillo, A. Bastone, M. Gobbi, S. Valentino, A. Doni, C. Garlanda, S. Danese, G. Salvatori, M. Sassano, V. Evangelista, B. Rossi, E. Zenaro, G. Constantin, C. Laudanna, B. Bottazzi and A. Mantovani: Regulation of leukocyte recruitment by the long pentraxin PTX3. Nat Immunol, 1, 328-34 (2010)
47. R. P. McEver: Rolling back neutrophil adhesion. Nat Immunol, 11, 282-4 (2010)
48. M. Salio, S. Chimenti, N. De Angelis, F. Molla, V. Maina, M. Nebuloni, F. Pasqualini, R. Latini, C. Garlanda and A. Mantovani: Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction. Circulation, 117, 1055-64 (2008)
49. K. Ebnet and D. Vestweber: Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines. Histochem Cell Biol, 112, 1-23 (1999) (Pubitemid 29356300)
50. A. Zarbock and K. Ley: Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol, 172, 1-7 (2008) (Pubitemid 351186361)
51. I. G. Colditz, M. A. Schneider, M. Pruenster and A. Rot: Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance. Thromb Haemost, 97, 688-93 (2007) (Pubitemid 46779955)
52. R. F. Bargatze, S. Kurk, E. C. Butcher and M. A. Jutila: Neutrophils roll on adherent neutrophils bound to cytokineinduced endothelial cells via L-selectin on the rolling cells. J Exp Med, 180, 1785-1792 (1994) (Pubitemid 24328569)
53. S. M. Buttrum, R. Hatton and G. B. Nash: Selectinmediated rolling of neutrophils on immobilized platelets. Blood, 82, 1165-74 (1993) (Pubitemid 23253990)
54. R. Alon, R. C. Fuhlbrigge, E. B. Finger and T. A. Springer: Interactions through L-selectin between leukocytes and adherent leukocytes nucleate rolling adhesions on selectins and VCAM-1 in shear flow. J Cell Biol, 135, 849-65 (1996) (Pubitemid 26372938)
55. C. A. St. Hill, S. R. Alexander and B. Walcheck: Indirect capture augments leukocyte accumulation on P selectin in flowing whole blood. J Leukoc Biol, 73, 464-471 (2003) (Pubitemid 38040092)
56. T. N. Mayadas, R. C. Johnson, H. Rayburn, R. O. Hynes and D. D. Wagner: Leukocyte rolling and extravasation are severely compromised in P selectindeficient mice. Cell, 74, 541-54 (1993) (Pubitemid 23244619)
57. M. L. Arbonés, D. C. Ord, K. Ley, H. Ratech, C. Maynard-Curry, G. Otten, D. J. Capon and T. F. Tedder: Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity, 1, 247-60 (1994)
58. M. A. Labow, C. R. Norton, J. M. Rumberger, K. M. Lombard-Gillooly, D. J. Shuster, J. Hubbard, R. Bertko, P. A. Knaack, R. W. Terry, M. L. Harbison, F. Kontgen, C. L. Stewart, K. W. McIntyre, P. C. Will, D. K. Burns and B. A. Wolitzky: Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins. Immunity, 1, 709-20 (1994) (Pubitemid 124000734)
59. V. Roldán, F. Marín, G. Y. Lip and A. D. Blann: Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature. Thromb Haemost 90, 1007-20 (2003) (Pubitemid 38004418)
60. P. H. Jakobsen, S. Morris-Jones, A. Rønn, Hviid, L, T. G. Theander, I. M. Elhassan, I. C. Bygbjerg and B. M. Greenwood: Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology, 83, 665-9 (1994) (Pubitemid 24374103)
61. K. Fassbender, R. Mössner, L. Motsch, U. Kischka, A. Grau and M. Hennerici: Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke, 26, 1361-4 (1995)
62. T. Kobayashi, S. Hashimoto, K. Imai, E. Amemiya, M. Yamaguchi, A. Yachi and T. Horie: Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and sE-selectin levels in bronchial asthma. Clin Exp Immunol, 96, 110-5 (1994) (Pubitemid 24213807)
63. W. Czech, E. Schöpf and A. Kapp: Soluble E-selectin in sera of patients with atopic dermatitis and psoriasis - correlation with disease activity. Br J Dermatol, 134, 17-21 (1996)
64. L. Kowalzick, A. Kleinheinz, K. Neuber, M. Weichenthal, I. Köhler and J. Ring: Elevated serum levels of soluble adhesion molecules ICAM-1 and ELAM-1 in patients with severe atopic eczema and influence of UVA1 treatment. Dermatology, 190, 14-8 (1995)
65. D. S. Kim and K. Y. Lee: Serum soluble E-selectin levels in Kawasaki disease. Scand J Rheumatol, 23, 283-6 (1994) (Pubitemid 24334036)
66. N. Oka, I. Akiguchi, T. Kawasaki, K. Ohnishi and J. Kimura: Elevated serum levels of endothelial leukocyte adhesion molecules in Guillain- Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Ann Neurol, 35, 621-4 (1994)
67. C. Wenisch, D. Myskiw, B. Parschalk, T. Hartmann, K. Dam and W. Graninger: Soluble endothelium-associated adhesion molecules in patients with Graves' disease. Clin Exp Immunol, 98, 240-4 (1994) (Pubitemid 24336820)
68. M. H. Ruchaud-Sparagano, E. M. Drost, S. C. Donnelly, M. I. Bird, C. Haslett and I. Dransfield: Potential pro-inflammatory effects of soluble E-selectin upon neutrophil function. Eur J Immunol, 28, 80-9 (1998) (Pubitemid 28048279)
69. M. S. Gruschwitz, O. P. Hornstein and P. von Den Driesch: Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum, 38, 184-9 (1995)
70. C. A. Facer and A. Theodoridou: Elevated plasma levels of P-selectin (GMP-140/CD62P) in patients with Plasmodium falciparum malaria. Microbiol Immunol, 38, 727-31 (1994)
71. F. Sakamaki, A. Ishizaka, M. Handa, S. Fujishima, T. Urano, K. Sayama, H. Nakamura, M. Kanazawa, T. Kawashiro, M. Katayama and Y. Ikeda: Soluble form of Pselectin in plasma is elevated in acute lung injury. Am J Respir Crit Care Med, 151, 1821-6 (1995)
72. C. Ehrhardt, C. Kneuer and U. Bakowsky: Selectins-an emerging target for drug delivery. Adv Drug Deliv Rev, 56, 527-49 (2004) (Pubitemid 38210421)
73. G. Wu, F. Li, P. Li and C. Ruan: Detection of plasma alpha-granule membrane protein GMP-140 using radiolabeled monoclonal antibodies in thrombotic diseases. Haemostasis, 23, 121-8 (1993) (Pubitemid 23251036)
74. I. Takeda, S. Kaise, T. Nishimaki and R. Kasukawa: Soluble P-selectin in the plasma of patients with connective tissue diseases. Int Arch Allergy Immunol, 105, 128-3 (1994)
75. K. Singbartl, S. A. Green and K. Ley: Blocking Pselectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J, 14, 48-54 (2000) (Pubitemid 30051522)
76. P. Mangell, A. Mihaescu, Y. Wang, R. Schramm, B. Jeppsson and H. Thorlacius: Critical role of P-selectindependent leukocyte recruitment in endotoxin-induced intestinal barrier dysfunction in mice. Inflamm Res, 56, 189-94 (2007) (Pubitemid 46985838)
77. K. Ley, D. C. Bullard, M. L. Arbonés, R. Bosse, D. Vestweber, T. F. Tedder and A. L. Beaudet: Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med 181, 669-75 (1995)
78. K. E. Norman, M. J. Cotter, J. B. Stewart, K. B. Abbitt, M. Ali, B. E. Wagner, W. A. Wallace, S. B. Forlow and P. G. Hellewell: Combined anticoagulant and antiselectin treatments prevent lethal intravascular coagulation. Blood, 101, 921-8 (2003) (Pubitemid 36139360)
79. R. G. Collins, R. Velji, N. V. Guevara, M. J. Hicks, L. Chan and A. L. Beaudet: P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein Edeficient mice. J Exp Med, 191, 189-94 (2000) (Pubitemid 30043660)
80. Z. M. Dong, A. A. Brown and D. D. Wagner: Prominent role of P-selectin in the development of advanced atherosclerosis in ApoE-deficient mice. Circulation, 101, 2290-5 (2000) (Pubitemid 30317132)
81. Y. Huo, A. Schober, S. B. Forlow, D. F. Smith, M. C. Hyman, S. Jung, D. R. Littman, C. Weber and K. Ley: Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med, 9, 61-7 (2003) (Pubitemid 36098261)
82. J. Rivera-Nieves, T. L. Burcin, T. S. Olson, M. A. Morris, M. McDuffie, F. Cominelli and K. Ley: Critical role of endothelial P-selectin glycoprotein ligand 1 in chronic murine ileitis. J Exp Med, 203, 907-17 (2006)
83. T. H. Rainer: L-selectin in health and disease. Resuscitation, 52, 127-41 (2002) (Pubitemid 34159022)
84. T. Collins, M. A. Read, A. S. Neish, M. Z. Whitley, D. Thanos and T. Maniatis: Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J, 9, 899-909 (1995)
85. K. Higai, A. Shimamura and K. Matsumoto: Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activation. Clin Chim Acta, 367, 137-43 (2006)
86. M. P. Bevilacqua, J. S. Pober, D. L. Mendrick, R. S. Cotran and M. A. J. Gimbrone: Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA, 84, 9238-42 (1987)
87. M. Hahne, U. Jäger, S. Isenmann, R. Hallmann and D. Vestweber: Five tumor necrosis factor-inducible cell adhesion mechanisms on the surface of mouse endothelioma cells mediate the binding of leukocytes. J Cell Biol 121, 655-64 (1993) (Pubitemid 23131276)
88. W. Kaszubska, R. Hooft van Huijsduijnen, P. Ghersa, A. M. DeRaemy-Schenk, B. P. Chen, T. Hai, J. F. DeLamarter and J. Whelan: Cyclic AMP-independent ATF family members interact with NF-kappa B and function in the activation of the E-selectin promoter in response to cytokines. Mol Cell Biol, 13, 7180-90 (1993) (Pubitemid 23321170)
89. C. Gaucher, C. Devaux, C. Boura, P. Lacolley, J. F. Stoltz and P. Menu: In vitro impact of physiological shear stress on endothelial cells gene expression profile. Clin Hemorheol Microcirc, 37, 99-107 (2007) (Pubitemid 47015816)
90. A. K. Stannard, R. Khurana, I. M. Evans, V. Sofra, D. I. Holmes and I. Zachary: Vascular endothelial growth factor synergistically enhances induction of E-selectin by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol, 27, 494-502 (2007)
91. C. J. Treutiger, G. E. Mullins, A. S. Johansson, A. Rouhiainen, H. M. Rauvala, H. Erlandsson-Harris, U. Andersson, H. Yang, K. J. Tracey, J. Andersson and J. E. Palmblad: High mobility group 1 B-box mediates activation of human endothelium. J Intern Med, 254, 375-85 (2003) (Pubitemid 37211261)
92. G. E. Rainger, M. P. Wautier, G. B. Nash and J. L. Wautier: Prolonged E-selectin induction by monocytes potentiates the adhesion of flowing neutrophils to cultured endothelial cells. Br J Haematol, 92, 192-9 (1996) (Pubitemid 26020700)
93. E. Cernuda-Morollón and A. J. Ridley: Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells. Circ Res, 98, 757-67 (2006)
94. B. N. Cronstein, S. C. Kimmel, R. I. Levin, F. Martiniuk and G. Weissmann: A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A, 89, 9991-5 (1992)
95. P. Ghersa, R. Hooft van Huijsduijnen, J. Whelan, Y. Cambet, R. Pescini and J. F. DeLamarter: Inhibition of Eselectin gene transcription through a cAMP-dependent protein kinase pathway. J Biol Chem, 269, 29129-37 (1994) (Pubitemid 24366765)
96. M. P. Bevilacqua, S. Stengelin, M. A. J. Gimbrone and B. Seed: Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science, 243, 1160-5 (1989) (Pubitemid 19081142)
97. K. Kobayashi, S. Matsumoto, T. Morishima, T. Kawabe and T. Okamoto: Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking Eselectin expression. Cancer Res, 60, 3978-84 (2000) (Pubitemid 32204595)
98. J. R. Gamble, Y. Khew-Goodall and M. A. Vadas: Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J Immunol, 150, 4494-503 (1993) (Pubitemid 23133726)
99. B. L. Bennett, R. Cruz, R. G. Lacson and A. M. Manning: Interleukin-4 suppression of tumor necrosis factor alphastimulated E-selectin gene transcription is mediated by STAT6 antagonism of NF-kappaB. J Biol Chem, 272, 10212-9 (1997) (Pubitemid 27171700)
100. L. Yao, J. Pan, H. Setiadi, K. D. Patel and R. P. McEver: Interleukin 4 or oncostatin M induces a prolonged increase in P-selectin mRNA and protein in human endothelial cells. J Exp Med, 184, 81-92 (1996) (Pubitemid 26247217)
101. G. Woltmann, C. A. McNulty, G. Dewson, F. A. Symon and A. J. Wardlaw: Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow. Blood, 95, 3146-52 (2000) (Pubitemid 30321166)
102. U. Gotsch, U. Jäger, M. Dominis and D. Vestweber: Expression of P-selectin on endothelial cells is upregulated by LPS and TNF-alpha in vivo. Cell Adhes Commun, 2, 7-14 (1994) (Pubitemid 24157841)
103. J. A. Auchampach, M. G. Oliver, D. C. Anderson and A. M. Manning: Cloning, sequence comparison and in vivo expression of the gene encoding rat P-selectin. Gene, 145, 251-5 (1994) (Pubitemid 24261444)
104. J. Pan and R. P. McEver: Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family. J Biol Chem, 270, 23077-83 (1995)
105. J. Pan, L. Xia and R. P. McEver: Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mechanisms for transcriptional regulation in endothelial cells. J Biol Chem, 273, 10058-67 (1998) (Pubitemid 28183109)
106. V. Modur, M. J. Feldhaus, A. S. Weyrich, D. L. Jicha, S. M. Prescott, G. A. Zimmerman and T. M. McIntyre: Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest, 100, 158-68 (1997) (Pubitemid 27311254)
107. M. Yoshida, B. E. Szente, J. M. Kiely, A. Rosenzweig and M. A. J. Gimbrone: Phosphorylation of the cytoplasmic domain of E-selectin is regulated during leukocyte-endothelial adhesion. J Immunol, 161, 933-41 (1998) (Pubitemid 28323559)
108. S. I. Simon, V. Cherapanov, I. Nadra, T. K. Waddell, S. M. Seo, Q. Wang, C. M. Doerschuk and G. P. Downey: Signaling functions of L-selectin in neutrophils: alterations in the cytoskeleton and colocalization with CD18. J Immunol, 163, 2891-901 (1999) (Pubitemid 29399220)
109. A. Levinovitz, J. Mühlhoff, S. Isenmann and D. Vestweber: Identification of a glycoprotein ligand for Eselectin on mouse myeloid cells. . J Cell Biol, 121, 449-459 (1993) (Pubitemid 23110887)
110. C. Laudanna, G. Constantin, P. Baron, E. Scarpini, G. Scarlato, G. Cabrini, C. Dechecchi, F. Rossi, M. A. Cassatella and G. Berton: Sulfatides trigger increase of cytosolic free calcium and enhanced expression of tumor necrosis factor-alpha and interleukin-8 mRNA in human neutrophils. Evidence for a role of L-selectin as a signaling molecule. J Biol Chem, 269, 4021-6 (1994)
111. X. Ba, C. Chen, Y. Gao and X. Zeng: Signaling function of PSGL-1 in neutrophil: tyrosine-phosphorylation-dependent and c-Abl-involved alteration in the F-actin-based cytoskeleton. J Cell Biochem, 94, 365-73 (2005) (Pubitemid 41420314)
112. C. Chen, X. Shang, T. Xu, L. Cui, J. Luo, X. Ba, S. Hao and X. Zeng: c-Abl is required for the signaling transduction induced by L-electin ligation. Eur J Immunol, 37, 3246-58 (2007) (Pubitemid 350131303)
113. Y. Hu, J. M. Kiely, B. E. Szente, A. Rosenzweig and M. A. J. Gimbrone: E-selectin-dependent signaling via the mitogen-activated protein kinase pathway in vascular endothelial cells. J Immunol, 165, 2142-8 (2000) (Pubitemid 30648751)
114. Y. Hu, B. E. Szente, J. M. Kiely and M. A. J. Gimbrone: Molecular events in transmembrane signaling via E-selectin. SHP2 association, adaptor protein complex formation and ERK1/2 activation. J Biol Chem, 276, 48549-53 (2001)
115. S. I. Simon, Y. Hu, D. Vestweber and C. W. Smith: Neutrophil tethering on E-selectin activates beta 2 integrin binding to ICAM-1 through a mitogen-activated protein kinase signal transduction pathway. J Immunol, 164, 4348-58 (2000) (Pubitemid 30215098)
116. A. Zarbock, C. L. Abram, M. Hundt, A. Altman, C. A. Lowell and K. Ley: PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling. J Exp Med, 205, 2339-47 (2008)
117. M. Yoshida, W. F. Westlin, N. Wang, D. E. Ingber, A. Rosenzweig, N. Resnick and M. A. J. Gimbrone: Leukocyte adhesion to vascular endothelium induces Eselectin linkage to the actin cytoskeleton. J Cell Biol, 133, 445-55 (1996) (Pubitemid 26132540)
118. M. A. Read, M. Z. Whitley, S. Gupta, J. W. Pierce, J. Best, R. J. Davis and T. Collins: Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem, 272, 2753-61 (1997) (Pubitemid 27053319)
119. J. E. Blanks, T. Moll, R. Eytner and D. Vestweber: Stimulation of P-selectin glycoprotein ligand-1 on mouse neutrophils activates beta 2-integrin mediated cell attachment to ICAM-1. Eur J Immunol, 28, 433-43 (1998) (Pubitemid 28101717)
120. A. Celi, G. Pellegrini, R. Lorenzet, A. De Blasi, N. Ready, B. C. Furie and B. Furie: P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A, 91, 8767-71 (1994)
121. A. S. Weyrich, M. R. Elstad, R. P. McEver, T. M. McIntyre, K. L. Moore, J. H. Morrissey, S. M. Prescott and G. A. Zimmerman: Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest, 97, 1525-34 (1996) (Pubitemid 26097043)
122. H. B. Wang, J. T. Wang, L. Zhang, Z. H. Geng, W. L. Xu, T. Xu, Y. Huo, X. Zhu, E. F. Plow, M. Chen and J. G. Geng: P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol, 8, 882-92 (2007) (Pubitemid 47099040)
123. V. Evangelista, Z. Pamuklar, A. Piccoli, S. Manarini, G. Dell'elba, R. Pecce, N. Martelli, L. Federico, M. Rojas, G. Berton, C. A. Lowell, L. Totani and S. S. Smyth: Src family kinases mediate neutrophil adhesion to adherent platelets. Blood, 109, 2461-9 (2007) (Pubitemid 46425889)
124. B. Furie and B. C. Furie: P-selectin and signal transduction. In: The Selectins. Ed M. A. Vadas&J. Harlan. Harwood, New York (1997)
125. S. A. Soltesz, E. A. Powers, J. G. Geng and C. Fisher: Adhesion of HT-29 colon carcinoma cells to E-selectin results in increased tyrosine phosphorylation and decreased activity of c-src. Int J Cancer, 71, 645-53 (1997) (Pubitemid 27239377)
126. J. Laferriere, F. Houle, M. M. Taher, K. Valerie and J. Huot: Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem, 276, 33762-72 (2001)
127. G. Poste and I. J. Fidler: The pathogenesis of cancer metastasis. Nature, 283, 139-46 (1980) (Pubitemid 10171124)
128. S. Paget: The distribution of secondary growth in cancer of the breast. Lancet, 1, 571-73 (1889)
129. J. Ewing: A treatise on tumors, neoplastic diseases. W.B. Saunders, Philadelphia (1928)
130. M. M. Burdick, J. M. McCaffery, Y. S. Kim, B. S. Bochner and K. Konstantopoulos: Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Phys - Cell Phys, 284, C977-87 (2003) (Pubitemid 36336954)
131. M. L. Majuri, P. Mattila and R. Renkonen: Recombinant E-selectin-protein mediates tumor cell adhesion via sialyl-Le(a) and sialyl-Le(x). Biochem Biophys Res Commun, 182, 1376-82 (1992)
132. C. J. Dimitroff, M. Lechpammer, D. Long-Woodward and J. L. Kutok: Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res, 64, 5261-9 (2004) (Pubitemid 39006546)
133. O. Insug, L. Otvos, T. Kieber-Emmons and M. Blaszczyk-Thurin: Role of SA-Le(a) and E-selectin in metastasis assessed with peptide antagonist. Peptides, 23, 999-1010 (2002) (Pubitemid 34657264)
134. S. Mathieu, M. Prorok, A. M. Benoliel, R. Uch, C. Langlet, P. Bongrand, R. Gerolami and A. El-Battari: Transgene expression of alpha(1,2)- fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin. Am J Pathol, 164, 371-83 (2004) (Pubitemid 38364653)
135. F. Haroun-Bouhedja, F. Lindenmeyer, H. Lu, C. Soria, J. Jozefonvicz and C. Boisson-Vidal: In vitro effects of fucans on MDA-MB231 tumor cell adhesion and invasion. Anticancer Res, 22, 2285-92 (2002) (Pubitemid 34857055)
136. T. Nübel, W. Dippold, H. Kleinert, B. Kaina and G. Fritz: Lovastatin inhibits Rho-regulated expression of Eselectin by TNFalpha and attenuates tumor cell adhesion. FASEB J, 18, 140-2 (2004)
137. L. Biancone, M. Araki, K. Araki, P. Vassalli and I. Stamenkovic: Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med, 183, 581-587 (1996) (Pubitemid 26060792)
138. C. F. Peeters, T. J. Ruers, J. R. Westphal and R. M. de Waal: Progressive loss of endothelial P-selectin expression with increasing malignancy in colorectal cancer. Lab Invest, 85, 248-56 (2005) (Pubitemid 40208928)
139. S. B. Fox, G. D. Turner, K. C. Gatter and A. L. Harris: The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium. J Pathol, 177, 369-76 (1995)
140. J. Renkonen, T. Paavonen and R. Renkonen: Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int J Cancer, 74, 296-300 (1997) (Pubitemid 27321799)
141. B. Mayer, H. Spatz, I. Funke, J. P. Johnson and F. W. Schildberg: De novo expression of the cell adhesion molecule E-selectin on gastric cancer endothelium. Langenbecks Arch Surg, 383, 81-6 (1998) (Pubitemid 28226344)
142. P. T. Nooijen, J. R. Westphal, A. M. Eggermont, C. Schalkwijk, R. Max, l. R. M. de Waa and D. J. Ruiter: Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis. Am J Pathol, 152, 679-82 (1998) (Pubitemid 28110714)
143. G. Velikova, R. E. Banks, A. Gearing, I. Hemingway, M. A. Forbes, S. R.
144. M. Hebbar, F. Révillion, M. M. Louchez, M. O. Vilain, C. Fournier, J. Bonneterre and J. P. Peyrat: The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer. Clin Cancer Res, 4, 373-80 (1998) (Pubitemid 28122752)
145. M. Cervello, L. Virruso, G. Lipani, L. Giannitrapani, M. Soresi, A. Carroccio, R. Gambino, R. Sanfililippo, L. Marasà and G. Montalto: Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. J Cancer Res Clin Oncol, 126, 345-51 (2000) (Pubitemid 30349573)
146. D. Taverna, H. Moher, D. Crowley, L. Borsig, A. Varki and R. O. Hynes: Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins. Proc Natl Acad Sci U S A, 101, 763-8 (2004) (Pubitemid 38121032)
147. O. V. Glinskii, V. H. Huxley, G. V. Glinsky, K. J. Pienta, A. Raz and V. V. Glinsky: Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia, 7, 522-7 (2005) (Pubitemid 40791870)
148. M. Satoh, K. Numahata, S. Kawamura, S. Saito and S. Orikasa: Lack of selectin-dependent adhesion in prostate cancer cells expressing sialyl Le(x). Int J Urol, 5, 86-91 (1998) (Pubitemid 28097237)
149. E. Meezan, H. C. Wu, P. H. Black and P. W. Robbins: Comparative studies on the carbohydrate-containing membrane components of normal and virus-transformed mouse fibroblasts. II. Separation of glycoproteins and glycopeptides by sephadex chromatography. Biochemistry, 8, 2518-24 (1969)
150. I. P. Witz: The selectin-selectin ligand axis in tumor progression. Cancer Metastasis Rev, 27, 19-30 (2008)
151. S. Hakomori: Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res, 56, 5309-5318 (1996) (Pubitemid 27011703)
152. S. Nakamori, M. Kameyama, S. Imaoka, H. Furukawa, O. Ishikawa, Y. Sasaki, T. Kabuto, T. Iwanaga, Y. Matsushita and T. Irimura: Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res, 53, 3632-3637 (1993) (Pubitemid 23229648)
153. T. Jørgensen, A. Berner, O. Kaalhus, K. J. Tveter, H. E. Danielsen and M. Bryne: Up-regulation of the oligosaccharide sialyl LewisX: a new prognostic parameter in metastatic prostate cancer. Cancer Res, 55, 1817-9 (1995)
154. K. Numahata, M. Satoh, K. Handa, S. Saito, C. Ohyama, A. Ito, T. Takahashi, S. Hoshi, S. Orikasa and S. I. Hakomori: Sialosyl-Le(x) expression defines invasive and metastatic properties of bladder carcinoma. Cancer, 94, 673-85 (2002) (Pubitemid 34132295)
155. T. Kishimoto, H. Ishikura, C. Kimura, T. Takahashi, H. Kato and T. Yoshiki: Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen. Int J Cancer, 69, 290-4 (1996) (Pubitemid 26298293)
156. S. Nakamori, H. Furukawa, M. Hiratsuka, T. Iwanaga, S. Imaoka, O. Ishikawa, T. Kabuto, Y. Sasaki, M. Kameyama, S. Ishiguro and T. Irimura: Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer. J Clin Oncol, 15, 816-25 (1997) (Pubitemid 27074253)
157. R. K. Jain, C. F. Piskorz, B. G. Huang, R. D. Locke, H. L. Han, A. Koenig, A. Varki and K. L. Matta: Inhibition of L- and P-selectin by a rationally synthesized novel core 2-like branched structure containing GalNAc-Lewisx and Neu5Acalpha2-3Galbeta1-3GalNAc sequences. Glycobiology, 8, 707-17 (1998) (Pubitemid 28331446)
158. C. A. St. Hill, D. Baharo-Hassan and M. Farooqui: C2-O-sLeX glycoproteins Are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells. PloS ONE, 6, e16281 (2011) doi:10.1371/journal.pone.0016281
159. C. A. St. Hill, K. M. Bullard and B. Walcheck: Expression of the high-affinity selectin glycan ligand C2-O-sLeX by colon carcinoma cells. Cancer Lett, 217, 105-113 (2005) (Pubitemid 39642871)
160. C. A. St. Hill, M. Farooqui, G. Mitcheltree, H. E. Gulbahce, J. Jessurun, Q. Cao and B. Walcheck: The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-Nacetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas. BMC Cancer, 9, 79 (2009)
161. K. Shimodaira, J. Nakayama, N. Nakamura, O. Hasebe, K. Tsutomu and M. Fukuda: Carcinoma-associated expression of core 2 β-1,6-N- acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res, 57, 5201-5206 (1997) (Pubitemid 27516348)
162. E. Machida, J. Nakayama, J. Amano and M. Fukuda: Clinicopathological significance of core 2 β1,6-Nacetylglucosaminyltransferase messenger RNA expressed in the pulmonary adenocarcinoma determined by in situ hybridization. Cancer Res, 61, 2226-2231 (2001) (Pubitemid 32692052)
163. J. Renkonen, J. Räbinä, P. Mattila, R. Grenman and R. Renkonen: Core 2 β1,6-N-acetylglucosaminyltransferases and α1,3- fucosyltransferases regulate the synthesis of Oglycans on selectin ligands on oral cavity carcinoma cells. APMIS, 109, 500-506 (2001) (Pubitemid 32844257)
164. S. Koop, E. E. Schmidt, I. C. MacDonald, V. L. Morris, R. Khokha, M. Grattan, J. Leone, A. F. Chambers and A. C. Groom: Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. Proc Natl Acad Sci U S A, 93, 11080-4 (1996)
165. B. F. Haynes, H. X. Liao and K. L. Patton: The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells, 3, 347-50 (1991)
166. S. Gout, P. L. Tremblay and J. Huot: Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis, 25, 335-44 (2008) (Pubitemid 351752950)
167. S. L. Napier, Z. R. Healy, R. L. Schnaar and K. Konstantopoulos: Selectin ligand expression regulates the initial vascular interactions of colon carcinoma cells: the roles of CD44v and alternative sialofucosylated selectin ligands. J Biol Chem, 282, 3433-41 (2007) (Pubitemid 47084453)
168. C. S. Alves, M. M. Burdick, S. N. Thomas, P. Pawar and K. Konstantopoulos: The dual role of CD44 as a functional P-selectin ligand and fibrin receptor in colon carcinoma cell adhesion. Am J Physiol Cell Physiol, 294, C907-16 (2008) (Pubitemid 351507918)
169. S. Gout, C. Morin, F. Houle and J. Huot: Death receptor-3, a new E-selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res, 66, 9117-9124 (2006) (Pubitemid 44521131)
170. A. M. Chinnaiyan, K. O'Rourke, G. L. Yu, R. H. Lyons, M. Garg, D. R. Duan, L. Xing, R. Gentz, J. Ni and V. M. Dixit: Signal transduction by DR3, a death domaincontaining receptor related to TNFR-1 and CD95. Science, 274, 990-2 (1996) (Pubitemid 26398422)
171. G. R. Screaton, X. N. Xu, A. L. Olsen, A. E. Cowper, R. Tan, A. J. McMichael and J. I. Bell: LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci U S A, 94, 4615-9 (1997) (Pubitemid 27194291)
172. P. L. Tremblay, F. A. Auger and J. Huot: Regulation of transendothelial migration of colon cancer cells by Eselectin-mediated activation of p38 and ERK MAP kinases. Oncogene, 25, 6563-6573 (2006) (Pubitemid 44646184)
173. L. M. Coussens and Z. Werb: Inflammation and cancer. Nature, 420, 860-7 (2002) (Pubitemid 36019639)
174. A. M. Khatib, M. Kontogiannea, L. Fallavollita, B. Jamison, S. Meterissian and P. Brodt: Rapid induction of cytokine and E-selectin expression in the liver in response to metastatic tumor cells. Cancer Res, 59, 1356-1361 (1999) (Pubitemid 29136269)
175. H. Läubli and L. Borsig: Selectins as mediators of lung metastasis. Cancer Microenviron, 3, 97-105 (2010)
176. A. M. Khatib, P. Auguste, L. Fallavollita, N. Wang, A. Samani, M. Kontogiannea, S. Meterissian and P. Brodt: Characterization of the host proinflammatory response to tumor cells during the initial stages of liver metastasis. Am J Pathol, 167, 749-59 (2005) (Pubitemid 41216359)
177. D. Alexiou, A. J. Karayiannakis, K. N. Syrigos, A. Zbar, A. Kremmyda, I. Bramis and C. Tsigris: Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer, 37, 2392-7 (2001) (Pubitemid 33097476)
178. J. S. Pober and W. C. Sessa: Evolving functions of endothelial cells in inflammation. Nat Rev Immunol, 7, 803-15 (2007) (Pubitemid 47480307)
179. H. Läubli, K. S. Spanaus and L. Borsig: Selectinmediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes. Blood, 114, 4583-91 (2009)
180. R. Giavazzi, M. Foppolo, R. Dossi and A. Remuzzi: Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest, 92, 3038-44 (1993) (Pubitemid 24006576)
181. A. Tözeren, H. K. Kleinman, D. S. Grant, D. Morales, A. M. Mercurio and S. W. Byers: E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int J Cancer, 60, 426-31 (1995)
182. B. McDonald, J. Spicer, B. Giannais, L. Fallavollita, P. Brodt and L. E. Ferri: Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer, 125, 1298-305 (2009)
183. B. Rossi and G. Constantin: Anti-selectin therapy for the treatment of inflammatory diseases. Inflamm Allergy Drug Targets, 7, 85-93 (2008)
184. K. Singbartl and K. Ley: Protection from ischemiareperfusion induced severe acute renal failure by blocking E-selectin. Crit Care Med, 28, 2507-14 (2000) (Pubitemid 30604461)
185. R. Owens, E. Ball, R. Ganesh, A. Nesbitt, D. Brown, C. Gofton, S. Stephens, L. Chaplin, M. Christofidou-Solomidou, S. Blake, D. Howat, W. A. Buurman, S. Albelda and M. K. Robinson: The in vivo and in vitro characterisation of an engineered human antibody to Eselectin. Immunotechnology, 3, 107-16 (1997) (Pubitemid 27356789)
186. M. Bhushan, T. O. Bleiker, A. E. Ballsdon, M. H. Allen, M. Sopwith, M. K. Robinson, C. Clarke, R. P. Weller, R. A. Graham-Brown, M. Keefe, J. N. Barker and C. E. Griffiths: Anti-E-selectin is ineffective in the treatment of psoriasis: a randomized trial. Br J Dermatol, 146, 824-31 (2002) (Pubitemid 34539192)
187. C. L. Lin, A. S. Dumont, T. Calisaneller, A. L. Kwan, S. L. Hwong and K. S. Lee: Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm. Surg Neurol, 64, 201-6 (2005) (Pubitemid 41140128)
188. J. W. Phillips, K. G. Barringhaus, J. M. Sanders, S. E. Hesselbacher, A. C. Czarnik, D. Manka, D. Vestweber, K. Ley and I. J. Sarembock: Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation, 107, 2244-9 (2003) (Pubitemid 36547220)
189. E. Aydt and G. Wolff: Development of synthetic panselectin antagonists: a new treatment strategy for chronic inflammation in asthma. Pathobiology, 70, 297-301 (2002-2003) (Pubitemid 36682978)
190. Y. Onai, J. Suzuki, Y. Nishiwaki, R. Gotoh, K. Berens, R. Dixon, M. Yoshida, H. Ito and M. Isobe: Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischemia/reperfusion injury. Eur J Pharmacol, 481, 217-25 (2003) (Pubitemid 37464973)
191. H. Takeda, M. Spatz, C. Ruetzler, R. McCarron, K. Becker and J. Hallenbeck: Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats. Stroke, 33, 2156-63 (2002) (Pubitemid 35014621)
192. S. N. Thomas, R. L. Schnaar and K. Konstantopoulos: Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells. Am J Physiol Cell Physiol, 296, C505-13 (2009)
193. J. L. Chen, W. X. Chen, J. S. Zhu, N. W. Chen, T. Zhou, M. Yao, D. Q. Zhang and Y. L. Wu: Effect of Pselectin monoclonal antibody on metastasis of gastric cancer and immune function. World J Gastroenterol, 9, 1607-10 (2003) (Pubitemid 36992366)
194. S. R. Barthel, J. D. Gavino, L. Descheny and C. J. Dimitroff: Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets, 11, 1473-91 (2007) (Pubitemid 350200482)
195. J. R. Brown, M. M. Fuster, R. Li, N. Varki, C. A. Glass and J. D. Esko: A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination. Clin Cancer Res, 12, 2894-901 (2006)
196. M. M. Fuster, J. R. Brown, L. Wang and J. D. Esko: A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res, 63, 2775-81 (2003) (Pubitemid 36667148)
197. J. L. Stevenson, S. H. Choi and A. Varki: Differential metastasis inhibition by clinically relevant levels of heparins - correlation with selectin inhibition, not antithrombotic activity. Clin Cancer Res, 11, 7003-11 (2005) (Pubitemid 41428760)
198. N. M. Kuderer, T. L. Ortel and C. W. Francis: Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol, 27, 4902-11 (2009)